A critical breakthrough in cancer research is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This crucial cancer suppressor protein is frequently disabled in several kinds of tumors, resulting https://worldsocialindex.com/story7058659/nanobodies-restore-p53-a-potential-hope-for-malignant-therapy